CardioVascular BioTherapeutics, Inc. (CVBT) - Financial and Strategic Analysis Review

GlobalData, August 2010, Pages: 25

Cardiovascular Biotherapeutics, Inc. (CVBT) is a biopharmaceutical company. It is engaged in the development of protein drugs for the treatment of regenerative cardiovascular diseases. The company's development stage product facilitates the growth of new blood vessels in the heart, tissues and organs. Its primary product candidate FGF-1 (141), is designed to facilitate the growth of new blood vessels in the heart and other tissues and organs with an impaired vascular system and is currently undergoing Phase II clinical trials for treatment of coronary heart disease. The company is headquartered in Las Vegas, United States.

This comprehensive SWOT profile of CardioVascular BioTherapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note-: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
CardioVascular BioTherapeutics, Inc. - Key Facts
CardioVascular BioTherapeutics, Inc. - Key Employees
CardioVascular BioTherapeutics, Inc. - Key Employee Biographies
CardioVascular BioTherapeutics, Inc. - Major Products and Services
CardioVascular BioTherapeutics, Inc. - History
CardioVascular BioTherapeutics, Inc. - Company Statement
CardioVascular BioTherapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
CardioVascular BioTherapeutics, Inc. - Business Description
CardioVascular BioTherapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
CardioVascular BioTherapeutics, Inc. - Strengths
Strength - Agreements
Strength - Proprietary Technology
CardioVascular BioTherapeutics, Inc. - Weaknesses
Weakness - Dependence on Single Supplier
Weakness - Increased Presence of Debt
CardioVascular BioTherapeutics, Inc. - Opportunities
Opportunity - Marketing Strategy
Opportunity - Molecules in Clinical Development
Opportunity - Market Potential
CardioVascular BioTherapeutics, Inc. - Threats
Threat - Emergence of Biogenerics/Biosimilars
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Competition
CardioVascular BioTherapeutics, Inc. - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

F. Hoffmann-La Roche Ltd.
Genentech, Inc.
GenVec, Inc.
Boston Scientific Corporation
Ortho-Clinical Diagnostics Inc.
Dade Behring Holdings, Inc. (Inactive)
bioMerieux S.A.
Sanofi-Aventis

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Sports and Fitness Nutrition - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report